Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
Clinical trial NCT03626922 · UNKNOWN
Trial details
- NCT number
- NCT03626922
- Sponsor
- NSABP Foundation Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2021-10-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.